Your browser doesn't support javascript.
loading
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
Munch-Petersen, Helga D; Asmar, Fazila; Dimopoulos, Konstantinos; Areskeviciute, Ausrine; Brown, Peter; Girkov, Mia Seremet; Pedersen, Anja; Sjö, Lene D; Heegaard, Steffen; Broholm, Helle; Kristensen, Lasse S; Ralfkiaer, Elisabeth; Grønbæk, Kirsten.
Affiliation
  • Munch-Petersen HD; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Department 3733, Copenhagen Biocenter, Building 2, 3rd floor, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark.
  • Asmar F; Department of Pathology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Dimopoulos K; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Department 3733, Copenhagen Biocenter, Building 2, 3rd floor, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark.
  • Areskeviciute A; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Department 3733, Copenhagen Biocenter, Building 2, 3rd floor, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark.
  • Brown P; Department of Pathology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Girkov MS; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Department 3733, Copenhagen Biocenter, Building 2, 3rd floor, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark.
  • Pedersen A; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Department 3733, Copenhagen Biocenter, Building 2, 3rd floor, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark.
  • Sjö LD; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Department 3733, Copenhagen Biocenter, Building 2, 3rd floor, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark.
  • Heegaard S; Department of Pathology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Broholm H; Department of Pathology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Kristensen LS; Department of Ophtalmology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Ralfkiaer E; Department of Pathology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Grønbæk K; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Department 3733, Copenhagen Biocenter, Building 2, 3rd floor, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark.
Acta Neuropathol Commun ; 4: 40, 2016 Apr 22.
Article in En | MEDLINE | ID: mdl-27101868
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Antineoplastic Combined Chemotherapy Protocols / Tumor Suppressor Protein p53 / Central Nervous System Neoplasms / Lymphoma / Mutation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Acta Neuropathol Commun Year: 2016 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Antineoplastic Combined Chemotherapy Protocols / Tumor Suppressor Protein p53 / Central Nervous System Neoplasms / Lymphoma / Mutation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Acta Neuropathol Commun Year: 2016 Document type: Article Affiliation country: Country of publication: